Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.69 | N/A |
PEG Ratio (TTM) | -0.03 | N/A |
P/S Ratio (TTM) | -2.96 | N/A |
P/B Ratio (TTM) | 0.82 | N/A |
P/FCF Ratio (TTM) | N/A | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -16.78% | N/A |
ROE (TTM) | -25.98% | N/A |
Net Profit Margin (TTM) | 110.08% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | N/A | -282.32% | N/A |
Revenue | N/A | 52.98% | N/A |
Net Income | N/A | -274.70% | N/A |
Cash Flow | N/A | N/A | N/A |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 7.26 | N/A |
Quick Ratio (TTM) | 7.26 | N/A |
D/E Ratio (TTM) | 0.80 | N/A |
Interest Coverage (TTM) | -1,453,962.64 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 16.89 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |